Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed Apr 16, 2013 · 10-K · 106 days after period end · 0001469709-13-000247
derived · Computed from the longer spans the company filed.
no prior Q4 2011 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2012 · filed Apr 16, 2013 · 106 d after period end
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
